Journal of Clinical Oncology · 2016 · 179 citations · 19 references
Hemithoracic IMPRINT for malignant pleural mesothelioma (MPM) is safe and has an acceptable rate of RP. Its incorporation with chemotherapy and P/D forms a new lung-sparing treatment paradigm for patients with locally advanced MPM.
19
Tom Treasure, Loı̈c Lang-Lazdunski, David Waller et al. · The Lancet Oncology · 2011 · 706 citations · Full text
Raja M. Flores, Harvey I. Pass, Venkatraman Seshan et al. · Journal of Thoracic and Cardiovascular Surgery · 2008 · 606 citations · Full text
Neuro-oncology, Surgical Oncology, Malignant Pleural Mesothelioma +6
Valerie W. Rusch, Kenneth E. Rosenzweig, Ennapadam Venkatraman et al. · Journal of Thoracic and Cardiovascular Surgery · 2001 · 493 citations · Full text
Surgical Oncology, Malignant Pleural Mesothelioma, Phase Ii Trial +7